Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-25-086732

Options or other derivatives

  • Director acquired 38,513 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rosenberg Anthony Director 2025-06-12 Grant or award · Stock Option (Right to Buy) +38,513 38,513 D
Loading xslF345X05/ownership.xml…